Kwinta P.
- Country
- Poland
- Department
- Oddział Pediatrii, Reumatologii i Chorób Rzadkich
Research Overview
Data & Insights
Has run more than one trial at 10 of 16 partner sites.
Specializations
Rare Genetic Disorders
This investigator specializes in the treatment and research of Mucopolysaccharidosis type II, also known as Hunter Syndrome, a rare genetic condition affecting multiple body systems.
- Genetic Disease Management
- Metabolic Disorders
- Lysosomal Storage Diseases
The investigator focuses on therapeutic interventions targeting both central nervous system and somatic manifestations of the disease.
Neurological Therapeutics
The investigator's work centers on developing treatments for CNS symptoms in patients with rare genetic disorders, with particular attention to long-term therapeutic outcomes.
- Central Nervous System Disorders
- Neurological Disease Progression
- Long-term Treatment Effects
Their research encompasses comprehensive evaluation of neurological manifestations and therapeutic responses in genetic disorders.
Treatment Innovation
The investigator evaluates novel therapeutic approaches for metabolic disorders, focusing on treatment safety and efficacy in chronic genetic conditions.
- Therapeutic Assessment
- Safety Monitoring
- Pharmacokinetic Studies
Their work involves comprehensive evaluation of innovative treatments for complex genetic disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.